BioCentriq is a New Jersey based cell and gene therapy contract development manufacturing organization (CDMO) with new state of the art facilities which are fully operational and registered with the FDA. Our goal is to advance the manufacturing of cell and gene therapies to make them more accessible to patients. Our process development and MSAT (Manufacturing Science and Technology) teams specialize in helping small and mid-size biotech optimize and scale their cell and gene therapies for clinical manufacturing. Get to know BioCentriq and experience the innovative, open, and collaborative approach we bring to every project

Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing a one-of-a-kind solution to overcome the limitations associated with manufacturing cell therapies that are more affordable and widely available to patients in need. With Cellares’ proprietary platform—the Cell Shuttle—biopharma companies, academic research centers and CDMOs will no longer have to compromise by either choosing a manufacturing platform that is semi-automated but lacks workflow flexibility, or one that provides customization but not the end-to-end automation needed to manufacture at scale. The company is headquartered in South San Francisco, Calif. For more information visit

Chemical and Pharmaceutical Solutions was founded in 2002. Our primary focus is servicing the emerging pharmaceutical market and to assist those companies in developing and commercializing their API’s. We look at both the technical and regulatory aspects of taking a product from early development through commercial launch. Working with outside partners, we look at economic drivers of your process and the technical challenges around scale up including improved purification methods as well as continuous flow chemistry. We also work closely with the Venture Capital firms to evaluate the technical and regulatory aspects of potential licensed products. Learn more.

Specializing in formulation development and commercial services for oral solid dosage products.
CMIC Group’s Cranbury, New Jersey, United States location is a contract manufacturing organization that specializes in the formulation development and commercial services for oral solid dosage products. We possess the industry expertise and capability to work with the most challenging solid dose formulations. As part of CMIC CMO group with global network, the site is planned for continue expansion of our development, analytical services and commercial manufacturing capacity and capabilities, demonstrates our commitment to provide the essential resources required to meet your present and future needs.  For more information, visit

Hetero USA is a group company of Hetero. Based in Piscataway, NJ, Hetero USA is a commercial sales organization, providing active pharmaceutical ingredients (API) and contract development and manufacturing (CDMO) services for both drug substance and drug products to our clients in the pharmaceutical industry. For more information, contact William Chelak at

Hovione is an international company with over 55 years experience in API development and compliant manufacture. With four FDA inspected sites in the U.S., China, Ireland, and Portugal, the company makes available branded pharmaceutical customers services for the development and compliant manufacture of innovative new drugs, is able to support highly potent compounds and offers proprietary product development and licensing opportunities for drug products. The company also undertakes the formulation development and clinical supply of the final dosage form to Phase II. In the inhalation area, Hovione offers APIs for inhalation, dry-powder inhalation devices, particle engineering and inhalation formulation development. Learn more.

JMS Pharma LLC. (dba: Agno Pharma NJ) was founded in 2020. This is a research and development service company which provides formulation development service for various dosage forms – injectables, ophthalmic, nasal, oral, topical etc. Formulation development services mainly focus on diversified forms of sterile products like solution, emulsion, suspension, powder, and lyophilized powder which can be delivered via vial, ampoule, prefilled syringe and cartridge. JMS also provides analytical services. Company’s long-term goal is to expand its capability to provide clinical supplies and small-scale commercial manufacturing.

KatalX is a next generation of “Trusted Digital Platform” where all stakeholders of the Supply Chain Ecosystem find TRUST, collaboration, visibility, analytics, and loopback to continuously improve operational excellence and sustainability. We focus on “Vital” supply chains (Pharma/Biotech/Medtech) for which supply chains have clearly become a strategic business enabler. In supply chains, sustainability is no more the “cherry on the cake” but a genuine business differentiator and a way to put company’s “Purpose in Action”, with real impact at scale.

PendoTECH offers technology for manufacturing & process development of biopharmaceuticals with a focus on unique single use in-line sensing technologies design specifically for the Biotechnology Industry. Along with the sensors are complementary product lines of software and hardware products that collect data from the sensors for analysis. Sensors include: Pressure, Temperature, UV Absorbance, Flow and Conductivity. These products assist users in meeting the FDA’s initiative in the area of PAT (process analytical technology) for QbD (Quality by Design) for manufacture of their products. Software / hardware expansion options are available to create a complete process control system for all unit operations in a biotech process. These options facilitate the integration the sensors and other devices such as pumps, scales, detectors and many more for both critical lab operations and for GMP production. Learn more.

TCG GreenChem, Inc. is the US subsidiary of TCG Lifesciences Pvt. Ltd., (formerly “Chembiotek Research International”) a leading global Contract Research and Manufacturing Services (CRAMS) company in the area of drug discovery, development and commercialization. TCG Lifesciences started operations in 2001 in Kolkata, India and currently has its presence in the United States, Europe, and Japan. TCG Lifesciences has a strong talent pool of 1000+ qualified and trained scientists (including 200+ PhDs) drawn from the best domestic and international institutes and industry. TCG GreenChem, Inc. is positioned as a contract innovation company that provides CDMO services with a unique modus operandi in the space of supporting pharmaceutical R&D. Moreover, through strategic collaborations with a select group of technology and manufacturing companies in United States, Asia, and Europe, TCG GreenChem, Inc. offers the cGMP manufacturing reliability in United States and India which is needed to meet today’s regulatory and supply-chain challenges.

Woodfield Distribution, LLC is a third-party logistics provider (3PL) specializing in supply chain solutions for the pharmaceutical industry. Our company occupies a 70,744 square foot facility, located in Boca Raton, FL., that performs functions including: receiving, storage and fulfillment, inventory and data management, reverse logistics, recall support, product disposition, physician sampling programs and pharmaceutical packaging. Woodfield Distribution, LLC’s facility is a secure environment that is climate controlled and is properly licensed to meet cGMP, PDMA, DEA, VAWD and other regulatory requirements. We are dedicated to the highest quality service and regulatory compliance to improve efficiency and reduce costs.  For more information, contact Larry Hotz at or 561-998-3885 x304. Learn more.

WuXi Biologics is a global Contract Research, Development and Manufacturing Organization (CRDMO) service company offering end-to-end solutions that empower our partners to discover, develop, and manufacture biopharmaceutical products. With operational facilities in New Jersey and Pennsylvania and another under construction in Massachusetts, we enable our partners to bring biologic solutions effectively and efficiently to patients through our comprehensive drug development model.